GENTA

pharmaceutical preparations which act by modulating gene expression for the treatment of neoplastic diseases, pathological conditions characterized by cellular hyperproliferation, pathological conditions characterized by over expression of a gene, pathological conditions characterized by undesired expression of a foreign gene [, and diseases caused by viral or bacterial agents]